August Pharmacy Pearls: Hyperlipidemia Management

August 28th, 2019 | Hyperlipidemia•Pharmacy Pearls•Cardiology

This edition of Pharmacy Pearls gives an overview of the recent updates made to the ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. This guideline (last updated in 2013) focuses on primary prevention in adults to reduce the risk of ASCVD (acute coronary syndromes, myocardial infarction, stable or unstable angina, arterial revascularization, stroke/transient ischemic attack, peripheral artery disease) and emphasizes patient‐specific treatment considerations, shared decision‐making, and a multidisciplinary team‐based approach in regards to implementation of recommended strategies. In this Pharmacy Pearl, you will find highlighted indications for treatment, a treatment
algorithm and a review of the available medications.

Please contact the Pharmacy Team with any questions or feedback you may have.

Taking too long?

Reload document

Open in new tab

Download PDF [379.95 KB]

ABI Value	Interpretation	Recommendation
Greater than 1.4	Calcification/vessel hardening	Refer to vascular specialist
1.0 - 1.4	Normal	None
0.9 - 1.0	Acceptable	None
0.8 - 0.9	Some arterial disease	Treat risk factor
0.5 - 0.8	Moderate arterial disease	Refer to vascular specialist
Less than 0.5	Severe arterial disease	Refer to vascular specialist

August Pharmacy Pearls: Hyperlipidemia Management

August Pharmacy Pearls: Hyperlipidemia Management

GENERAL COVID-19 INFORMATION